_version_ 1785041780697202688
author Cuesta, P. Casado
Díaz, F. Pikabea
Galve-Calvo, E.
Zumarraga, A.
Penas, A. Bilbao
De San Vicente, B. López
Bejarano, C. Figaredo
Pina, I. Bernat
Legaspi, J.
Galíndez, J.R. Barceló
Sardina, L. Sande
NuÑo Escolastico, M.
Abad Villar, M.T.
Lopez, M.
Pérez Hoyos, M.T.
Sala Gonzalez, M.A.
Francés, M. Temiño
Jaramillo, P.L. Loaiza
Díaz de Tuesta del Arco, J.L.
Martinez del Prado, P.
author_facet Cuesta, P. Casado
Díaz, F. Pikabea
Galve-Calvo, E.
Zumarraga, A.
Penas, A. Bilbao
De San Vicente, B. López
Bejarano, C. Figaredo
Pina, I. Bernat
Legaspi, J.
Galíndez, J.R. Barceló
Sardina, L. Sande
NuÑo Escolastico, M.
Abad Villar, M.T.
Lopez, M.
Pérez Hoyos, M.T.
Sala Gonzalez, M.A.
Francés, M. Temiño
Jaramillo, P.L. Loaiza
Díaz de Tuesta del Arco, J.L.
Martinez del Prado, P.
author_sort Cuesta, P. Casado
collection PubMed
description
format Online
Article
Text
id pubmed-10182558
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101825582023-05-15 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer Cuesta, P. Casado Díaz, F. Pikabea Galve-Calvo, E. Zumarraga, A. Penas, A. Bilbao De San Vicente, B. López Bejarano, C. Figaredo Pina, I. Bernat Legaspi, J. Galíndez, J.R. Barceló Sardina, L. Sande NuÑo Escolastico, M. Abad Villar, M.T. Lopez, M. Pérez Hoyos, M.T. Sala Gonzalez, M.A. Francés, M. Temiño Jaramillo, P.L. Loaiza Díaz de Tuesta del Arco, J.L. Martinez del Prado, P. ESMO Open Article Elsevier 2023-05 2023-05-13 /pmc/articles/PMC10182558/ http://dx.doi.org/10.1016/j.esmoop.2023.101371 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cuesta, P. Casado
Díaz, F. Pikabea
Galve-Calvo, E.
Zumarraga, A.
Penas, A. Bilbao
De San Vicente, B. López
Bejarano, C. Figaredo
Pina, I. Bernat
Legaspi, J.
Galíndez, J.R. Barceló
Sardina, L. Sande
NuÑo Escolastico, M.
Abad Villar, M.T.
Lopez, M.
Pérez Hoyos, M.T.
Sala Gonzalez, M.A.
Francés, M. Temiño
Jaramillo, P.L. Loaiza
Díaz de Tuesta del Arco, J.L.
Martinez del Prado, P.
275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title_full 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title_fullStr 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title_full_unstemmed 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title_short 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer
title_sort 275p serological response to covid-19 vaccine in patients with advanced breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182558/
http://dx.doi.org/10.1016/j.esmoop.2023.101371
work_keys_str_mv AT cuestapcasado 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT diazfpikabea 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT galvecalvoe 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT zumarragaa 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT penasabilbao 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT desanvicenteblopez 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT bejaranocfigaredo 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT pinaibernat 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT legaspij 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT galindezjrbarcelo 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT sardinalsande 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT nunoescolasticom 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT abadvillarmt 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT lopezm 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT perezhoyosmt 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT salagonzalezma 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT francesmtemino 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT jaramilloplloaiza 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT diazdetuestadelarcojl 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer
AT martinezdelpradop 275pserologicalresponsetocovid19vaccineinpatientswithadvancedbreastcancer